Brief: Implanet gets CE mark and FDA clearance for new JAZZ diameters
May 19 (Reuters) - Implanet SA IMPL.PA
* Receives CE mark and FDA clearance in United States for
new JAZZ diameters
* This clearance addresses treatment of adolescent scoliosis
and treatment of deformity and degenerative spinal disorders in
adults
Source text for Eikon: ID:nBw8HKHgja
Further company coverage: IMPL.PA
(Gdynia Newsroom:)
((Gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))
Recent news on Implanet SA
See all newsFrench orthopedic implants maker Implanet's nine-month revenue jumps, partly on strong US momentum
French and Benelux stocks-Factors to watch on September 16
France's IMPLANET H1 revenue rises on medical equipment strength, US growth
Brief: IMPLANET H1 Revenue EUR 7.1 Million
France's IMPLANET H1 revenue rises on spine implants strength, US growth